Table 3 Deaths, the median number of days of survival and odds ratio for fatty acids below or above level of skeletal muscle phospholipid fatty acids in cancer patients.
Cut-point levela (ng/mg) | Below cut-point | Above cut-point | Cox regression analysis (categorical variable) | ||||||
|---|---|---|---|---|---|---|---|---|---|
No. of patients, N | Event, N (%) | Survival time (median) | No. of patients, N | Event, N (%) | Survival time (median) | HR (95% CI) | p-value | ||
Palmitoleic acid (16:1) | 20.5 | 17 | 5 (29) | 642 | 16 | 11 (69) | 493 | 0.34 (0.11–0.99) | 0.049 |
AA (20:4n-6) | 136.9 | 19 | 12 (63) | 478 | 14 | 4 (28) | 742 | 3.45 (1.1–10.8) | 0.033 |
EPA (20:5n-3) | 7.2 | 20 | 13 (65) | 480 | 13 | 3 (23) | 719 | 4.39 (1.2–15.5) | 0.022 |
DHA (22:6n-3) | 25.2 | 21 | 13 (62) | 477 | 12 | 3 (25) | 806 | 4.30 (1.2–15.3) | 0.024 |
